stronger neominophagen c has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Hu, XY; Liu, JL; Liu, XY; Luo, JX; Nie, HM; Wen, DC; Zhang, Y | 1 |
| Ando, M; Gondo, T; Hidaka, I; Hino, K; Korenaga, M; Nishina, S; Okuda, M; Sakaida, I | 1 |
2 other study(ies) available for stronger neominophagen c and Liver Dysfunction
| Article | Year |
|---|---|
Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-ΚB/caspase-3 and PCNA signaling pathways.
Topics: Aconitum; Animals; Caspase 3; Cysteine; Drug Combinations; Galactosamine; Glycine; Glycyrrhetinic Acid; HMGB1 Protein; Liver; Liver Diseases; Male; NF-kappa B; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4 | 2016 |
Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
Topics: Alanine Transaminase; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cysteine; Cytochrome P-450 CYP2E1; Disease Models, Animal; Drug Combinations; Glutamate-Cysteine Ligase; Glutathione; Glycine; Glycyrrhetinic Acid; Hepacivirus; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Liver; Oxidative Stress; Polyproteins; RNA, Messenger; Viral Proteins | 2007 |